Literature DB >> 11817519

Immunohistochemical localization of GABAB receptor in the entorhinal cortex and inferior temporal cortex of schizophrenic brain.

Katsuyoshi Mizukami1, Masanori Ishikawa, Shin Hidaka, Masahiko Iwakiri, Megumi Sasaki, Shuji Iritani.   

Abstract

Immunocytochemical techniques were employed to examine the changes in immunolabeling of the gamma-aminobutyric acid (GABA)B receptor within the entorhinal cortex and inferior temporal isocortex of the schizophrenic brain. In the entorhinal cortex of the control subjects, an intense immunoreactivity was observed in the soma and processes of stellate cells in Layer II, in pyramidal cells in Layers II, III, and V, and in nonpyramidal interneurons. In subjects with schizophrenia, GABA(B) immunoreactivity was markedly reduced in pyramidal cells throughout the layers. In the inferior temporal cortex of the controls, both pyramidal cells and nonpyramidal interneurons demonstrated an intense immunoreactivity, while in the same region of the schizophrenic brain a marked reduction of the GABA(B) immunolabeling was observed in pyramidal cells in Layer V. These findings suggest that in the entorhinal cortex and the inferior temporal cortex of the schizophrenic brain, the expression of the GABA(B) receptor is reduced, and raise the possibility that GABA(B) receptor dysfunction is involved in the pathophysiology of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11817519     DOI: 10.1016/s0278-5846(01)00247-0

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  26 in total

Review 1.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

2.  Effects of GABA-B receptor positive modulator on ketamine-induced psychosis-relevant behaviors and hippocampal electrical activity in freely moving rats.

Authors:  Jingyi Ma; L Stan Leung
Journal:  Psychopharmacology (Berl)       Date:  2017-07-29       Impact factor: 4.530

3.  GABA(B) receptor blockade in the hippocampus affects sensory and sensorimotor gating in Long-Evans rats.

Authors:  Jingyi Ma; L Stan Leung
Journal:  Psychopharmacology (Berl)       Date:  2011-04-12       Impact factor: 4.530

Review 4.  The GABAβ receptor as a target for antidepressant drug action.

Authors:  Subroto Ghose; Michelle K Winter; Kenneth E McCarson; Carol A Tamminga; Salvatore J Enna
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

Review 5.  GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.

Authors:  Meng-Yi Xu; Albert H C Wong
Journal:  Acta Pharmacol Sin       Date:  2018-03-22       Impact factor: 6.150

6.  Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia.

Authors:  Harry Pantazopoulos; Nicholas Lange; Ross J Baldessarini; Sabina Berretta
Journal:  Biol Psychiatry       Date:  2006-09-01       Impact factor: 13.382

7.  Realistic modeling of entorhinal cortex field potentials and interpretation of epileptic activity in the guinea pig isolated brain preparation.

Authors:  E Labyt; L Uva; M de Curtis; F Wendling
Journal:  J Neurophysiol       Date:  2006-04-05       Impact factor: 2.714

8.  Expression of the Rap1 guanine nucleotide exchange factor, MR-GEF, is altered in individuals with bipolar disorder.

Authors:  Angela Bithell; Tony Hsu; Apsara Kandanearatchi; Sabine Landau; Ian P Everall; Ming T Tsuang; Gursharan Chana; Brenda P Williams
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

9.  GABA(B) receptor activation inhibits neuronal excitability and spatial learning in the entorhinal cortex by activating TREK-2 K+ channels.

Authors:  Pan-Yue Deng; Zhaoyang Xiao; Chuanxiu Yang; Lalida Rojanathammanee; Laurel Grisanti; John Watt; Jonathan D Geiger; Rugao Liu; James E Porter; Saobo Lei
Journal:  Neuron       Date:  2009-07-30       Impact factor: 17.173

10.  Baclofen reverses the reduction in prepulse inhibition of the acoustic startle response induced by dizocilpine, but not by apomorphine.

Authors:  Marco Bortolato; Roberto Frau; Gian Nicola Aru; Marco Orrù; Gian Luigi Gessa
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.